Labex Corporation to distribute ImmunoReagents antibodies in India

ImmunoReagents has appointed Labex as its new distributor in India.

ImmunoReagents, a global manufacturer of polyclonal antibodies, has chosen Labex Corporation to distribute its products in India.

The company manufactures antibodies that are used by researchers, as well as by pharmaceutical and biotechnology companies.

It regards India as an important biotech market, since the industry is one of the country's fastest growing sectors.

Ann Black, president and chief executive officer of ImmunoReagents, described the appointment of Labex Corporation as its new distributor in India as a "great step" for the company.

"Our partnership with Labex will allow us to introduce our products into one of the world's most promising biotech markets," she remarked.

India is expected to become a major player in the global biotechnology market, with the industry contributing to its rapidly growing economy.

The country reported revenues of $3 billion in 2009-10, with its pharmaceutical sector attracting $1.67 billion in foreign investment between 2000 and 2012.

India is one of the four so-called 'BRIC' emerging economies, alongside Brazil, Russia and China.